+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Prostatic Artery Embolization Market Size, Share & Trends Analysis Report 2026-2033

  • PDF Icon

    Report

  • 210 Pages
  • October 2026
  • Region: Global
  • Grand View Research
  • ID: 6292300
The global prostatic artery embolization market size was valued at USD 102.8 million in 2025 and is projected to grow from USD 110.4 million in 2026 to USD 185.0 million by 2033, at a CAGR of 7.7% from 2026 to 2033. The market in North America dominated with a revenue share of 35.5% in 2025. The market growth is driven by the increasing prevalence of benign prostatic hyperplasia (BPH), rising preference for minimally invasive treatment options, growing adoption of image-guided interventional procedures, and increasing demand for alternatives to conventional surgical interventions for managing lower urinary tract symptoms.

The increasing number of men requiring treatment for urinary obstruction, frequency, urgency, and other BPH-related symptoms is expanding the potential patient pool for minimally invasive interventions. Also, growing clinical evidence supporting the safety and effectiveness of PAE is strengthening its acceptance among urologists, interventional radiologists, and patients. For instance, in September 2024, an international multicenter prospective study of 478 patients undergoing PAE for symptomatic BPH. The study reported significant and sustained reductions in IPSS and improvements in quality of life through 24 months. Among patients treated for acute urinary retention, 65.8% became catheter-free within 3 months and remained catheter-free at 24 months. Only 2.1% experienced a serious adverse event. The authors concluded that PAE was a safe and effective treatment for symptomatic BPH and LUTS.

The incidence of benign prostatic hyperplasia (BPH) increased consistently from 14.01 million cases in 2021 to 14.42 million in 2022, 14.70 million in 2023, and 15.07 million in 2024. This represents an increase of approximately 1.06 million cases, or 7.6%, over the four-year period. The annual increase indicates a continuing rise in the number of men affected by BPH, creating a larger population requiring diagnosis, symptom management, and treatment. This increasing disease burden provides a growing patient base for minimally invasive BPH interventions, including prostatic artery embolization (PAE).

Global Prostatic Artery Embolization Market Report Segmentation

This report forecasts revenue growth at global, regional & country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the global prostatic artery embolization market report based on product, application, end use, and region:

Product Outlook (Revenue, USD Million, 2021 - 2033)

  • Embolic Agents
  • Spherical Microspheres
  • Tris-acryl Gelatin Microspheres
  • PVA-based Microspheres
  • Hydrogel Microspheres
  • Non-spherical Polyvinyl Alcohol (PVA) Particles
  • Other Embolic Agents
  • Delivery and Access Devices
  • Microcatheters
  • Standard Microcatheters
  • Reflux-Control Microcatheters
  • Balloon-Occlusion Microcatheters
  • Steerable Microcatheters
  • Guidewires and Micro Guidewires
  • Diagnostic/ Guiding Catheters
  • Other Procedural Accessories

Application Outlook (Revenue, USD Million, 2021 - 2033)

  • Benign Prostatic Hyperplasia (BPH)
  • Urinary Retention
  • Prostatic Bleeding
  • Prostate Cancer Symptom Management
  • Other Prostatic Conditions

End Use Outlook (Revenue, USD Million, 2021 - 2033)

  • Hospitals & Academic Medical Centers
  • Ambulatory Surgical Centers
  • Office-Based Labs (OBLs) & Outpatient IR Clinics

Regional Outlook (Revenue, USD Million, 2021 - 2033)

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Asia Pacific
  • Japan
  • China
  • India
  • Thailand
  • Australia
  • South Korea
  • Latin America
  • Brazil
  • Argentina
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Product
1.1.2. Application
1.1.3. End Use
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline
1.2. Market Definitions
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. The internal database
1.5. Details of primary research
1.5.1. Data for primary interviews in North America
1.5.2. Data for primary interviews in Europe
1.5.3. Data for primary interviews in Asia Pacific
1.5.4. Data for primary interviews in Latin America
1.5.5. Data for Primary interviews in MEA
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.1.1. Approach 1: Commodity flow approach
1.7.2. Volume price analysis (Model 2)
1.7.2.1. Approach 2: Volume price analysis
1.8. Research Scope and Assumptions
1.8.1. List of Secondary Sources
1.8.2. List of Primary Sources
1.8.3. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Prostatic Artery Embolization Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Drivers Analysis
3.2.1.1. Rising prevalence of benign prostatic hyperplasia (BPH) and lower urinary tract symptoms
3.2.1.2. Advancements in image-guided and catheter-based technologies
3.2.1.3. Growing acceptance of PAE in clinical guidelines and practice
3.2.1.4. Rising preference for minimally invasive BPH treatment
3.2.2. Market Restraints Analysis
3.2.2.1. Higher reintervention rates compared with some surgical treatments
3.2.2.2. Technical complexity and dependence on experienced interventional radiologists
3.2.3. Market Opportunity Analysis
3.2.3.1. Expansion of PAE into patients with urinary retention
3.2.3.2. Development of next-generation embolic agents
3.2.3.3. Increasing use of cone-beam CT and advanced procedural navigation
3.2.3.4. Expansion of outpatient and same-day PAE pathways
3.2.3.5. Increasing use in patients with large prostates and medically complex patients
3.2.4. Market Challenge Analysis
3.2.4.1. Complex prostatic arterial anatomy and risk of non-target embolization
3.2.4.2. Lack of complete long-term standardization across embolic agents and procedural techniques
3.3. Prostatic Artery Embolization Market Analysis Tools
3.3.1. Porter’s Analysis
3.3.1.1. Bargaining power of the suppliers
3.3.1.2. Bargaining power of the buyers
3.3.1.3. Threats of substitution
3.3.1.4. Threats from new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic and Social landscape
3.3.2.3. Technological landscape
3.3.2.4. Environmental landscape
3.3.2.5. Legal landscape
Chapter 4. Prostatic Artery Embolization Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global Prostatic Artery Embolization Market: Product Movement Analysis, 2025 & 2033 (USD Million)
4.3. Global Prostatic Artery Embolization Market Size & Trend Analysis, Product, 2021 to 2033 (USD Million)
4.4. Embolic Agents
4.4.1. Embolic agents market revenue estimates and forecasts, 2021 - 2033 (USD Million)
4.4.2. Spherical Microspheres
4.4.2.1. Spherical microspheres market revenue estimates and forecasts, 2021 - 2033 (USD Million)
4.4.2.2. Tris-acryl Gelatin Microspheres
4.4.2.3. Tris-acryl gelatin microspheres market revenue estimates and forecasts, 2021 - 2033 (USD Million)
4.4.2.4. PVA-based Microspheres
4.4.2.5. PVA-based microspheres market revenue estimates and forecasts, 2021 - 2033 (USD Million)
4.4.2.6. Hydrogel Microspheres
4.4.2.7. Hydrogel microspheres market revenue estimates and forecasts, 2021 - 2033 (USD Million)
4.4.3. Non-spherical Polyvinyl Alcohol (PVA) Particles
4.4.3.1. Non-spherical polyvinyl alcohol (PVA) particles market revenue estimates and forecasts, 2021 - 2033 (USD Million)
4.4.4. Other Embolic Agents
4.4.4.1. Other embolic agents market revenue estimates and forecasts, 2021 - 2033 (USD Million)
4.5. Delivery and Access Devices
4.5.1. Delivery and access devices market revenue estimates and forecasts, 2021 - 2033 (USD Million)
4.5.2. Microcatheters
4.5.2.1. Microcatheters market revenue estimates and forecasts, 2021 - 2033 (USD Million)
4.5.2.2. Standard Microcatheters
4.5.2.2.1. Standard microcatheters market revenue estimates and forecasts, 2021 - 2033 (USD Million)
4.5.2.3. Reflux-Control Microcatheters
4.5.2.3.1. Reflux-control microcatheters market revenue estimates and forecasts, 2021 - 2033 (USD Million)
4.5.2.4. Balloon-Occlusion Microcatheters
4.5.2.4.1. Balloon-occlusion microcatheters market revenue estimates and forecasts, 2021 - 2033 (USD Million)
4.5.2.5. Steerable Microcatheters
4.5.2.5.1. Steerable microcatheters market revenue estimates and forecasts, 2021 - 2033 (USD Million)
4.5.3. Guidewires and Micro Guidewires
4.5.3.1. Guidewires and micro guidewires market revenue estimates and forecasts, 2021 - 2033 (USD Million)
4.5.4. Diagnostic/ Guiding Catheters
4.5.4.1. Diagnostic/ guiding catheters market revenue estimates and forecasts, 2021 - 2033 (USD Million)
4.5.5. Other Procedural Accessories
4.5.5.1. Other procedural accessories market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 5. Prostatic Artery Embolization Market: Application Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Global Prostatic Artery Embolization Market: Application Movement Analysis, 2025 & 2033 (USD Million)
5.3. Global Prostatic Artery Embolization Market Size & Trend Analysis, Application 2021 to 2033 (USD Million)
5.4. Benign Prostatic Hyperplasia (BPH)
5.4.1. Benign prostatic hyperplasia (BPH) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
5.5. Urinary Retention
5.5.1. Urinary retention market revenue estimates and forecasts, 2021 - 2033 (USD Million)
5.6. Prostatic Bleeding
5.6.1. Prostatic bleeding market revenue estimates and forecasts, 2021 - 2033 (USD Million)
5.7. Prostate Cancer Symptom Management
5.7.1. Prostate cancer symptom management market revenue estimates and forecasts, 2021 - 2033 (USD Million)
5.8. Other Prostatic Conditions
5.8.1. Other prostatic conditions market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 6. Prostatic Artery Embolization Market: End Use Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Global Prostatic Artery Embolization Market: End Use Movement Analysis, 2025 & 2033 (USD Million)
6.3. Global Prostatic Artery Embolization Market Size & Trend Analysis, End Use, 2021 to 2033 (USD Million)
6.4. Hospitals & Academic Medical Centers
6.4.1. Hospitals & academic medical centers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
6.5. Ambulatory Surgical Centers
6.5.1. Ambulatory surgical centers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
6.6. Office-Based Labs (OBLs) & Outpatient IR Clinics
6.6.1. Office-based labs (OBLs) & outpatient IR clinics market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 7. Prostatic Artery Embolization Market: Regional Estimates & Trend Analysis by Product, Application, and End Use
7.1. Regional Dashboard
7.2. Market Size and Trend Analysis, 2021 to 2033
7.3. North America
7.3.1. North America prostatic artery embolization market estimates and forecasts, 2021 - 2033 (USD Million)
7.3.2. U.S.
7.3.2.1. Key country dynamics
7.3.2.2. Competitive scenario
7.3.2.3. Regulatory framework
7.3.2.4. Reimbursement scenario
7.3.2.5. U.S. prostatic artery embolization market estimates and forecasts, 2021 - 2033 (USD Million)
7.3.3. Canada
7.3.3.1. Key country dynamics
7.3.3.2. Competitive scenario
7.3.3.3. Regulatory framework
7.3.3.4. Reimbursement scenario
7.3.3.5. Canada prostatic artery embolization market estimates and forecasts, 2021 - 2033 (USD Million)
7.3.4. Mexico
7.3.4.1. Key country dynamics
7.3.4.2. Competitive scenario
7.3.4.3. Regulatory framework
7.3.4.4. Reimbursement scenario
7.3.4.5. Mexico prostatic artery embolization market estimates and forecasts, 2021 - 2033 (USD Million)
7.4. Europe
7.4.1. Europe prostatic artery embolization market estimates and forecasts, 2021 - 2033 (USD Million)
7.4.2. UK
7.4.2.1. Key country dynamics
7.4.2.2. Competitive scenario
7.4.2.3. Regulatory framework
7.4.2.4. Reimbursement scenario
7.4.2.5. UK prostatic artery embolization market estimates and forecasts, 2021 - 2033 (USD Million)
7.4.3. Germany
7.4.3.1. Key country dynamics
7.4.3.2. Competitive scenario
7.4.3.3. Regulatory framework
7.4.3.4. Reimbursement scenario
7.4.3.5. Germany prostatic artery embolization market estimates and forecasts, 2021 - 2033 (USD Million)
7.4.4. France
7.4.4.1. Key country dynamics
7.4.4.2. Competitive scenario
7.4.4.3. Regulatory framework
7.4.4.4. Reimbursement scenario
7.4.4.5. France prostatic artery embolization market estimates and forecasts, 2021 - 2033 (USD Million)
7.4.5. Italy
7.4.5.1. Key country dynamics
7.4.5.2. Competitive scenario
7.4.5.3. Regulatory framework
7.4.5.4. Reimbursement scenario
7.4.5.5. Italy prostatic artery embolization market estimates and forecasts, 2021 - 2033 (USD Million)
7.4.6. Spain
7.4.6.1. Key country dynamics
7.4.6.2. Competitive scenario
7.4.6.3. Regulatory framework
7.4.6.4. Reimbursement scenario
7.4.6.5. Spain prostatic artery embolization market estimates and forecasts, 2021 - 2033 (USD Million)
7.4.7. Sweden
7.4.7.1. Key country dynamics
7.4.7.2. Competitive scenario
7.4.7.3. Regulatory framework
7.4.7.4. Reimbursement scenario
7.4.7.5. Sweden prostatic artery embolization market estimates and forecasts, 2021 - 2033 (USD Million)
7.4.8. Denmark
7.4.8.1. Key country dynamics
7.4.8.2. Competitive scenario
7.4.8.3. Regulatory framework
7.4.8.4. Reimbursement scenario
7.4.8.5. Denmark prostatic artery embolization market estimates and forecasts, 2021 - 2033 (USD Million)
7.4.9. Norway
7.4.9.1. Key country dynamics
7.4.9.2. Competitive scenario
7.4.9.3. Regulatory framework
7.4.9.4. Reimbursement scenario
7.4.9.5. Norway prostatic artery embolization market estimates and forecasts, 2021 - 2033 (USD Million)
7.5. Asia Pacific
7.5.1. Asia Pacific prostatic artery embolization market estimates and forecasts, 2021 - 2033 (USD Million)
7.5.2. China
7.5.2.1. Key country dynamics
7.5.2.2. Competitive scenario
7.5.2.3. Regulatory framework
7.5.2.4. Reimbursement scenario
7.5.2.5. China prostatic artery embolization market estimates and forecasts, 2021 - 2033 (USD Million)
7.5.3. Japan
7.5.3.1. Key country dynamics
7.5.3.2. Competitive scenario
7.5.3.3. Regulatory framework
7.5.3.4. Reimbursement scenario
7.5.3.5. Japan prostatic artery embolization market estimates and forecasts, 2021 - 2033 (USD Million)
7.5.4. India
7.5.4.1. Key country dynamics
7.5.4.2. Competitive scenario
7.5.4.3. Regulatory framework
7.5.4.4. Reimbursement scenario
7.5.4.5. India prostatic artery embolization market estimates and forecasts, 2021 - 2033 (USD Million)
7.5.5. South Korea
7.5.5.1. Key country dynamics
7.5.5.2. Competitive scenario
7.5.5.3. Regulatory framework
7.5.5.4. Reimbursement scenario
7.5.5.5. South Korea prostatic artery embolization market estimates and forecasts, 2021 - 2033 (USD Million)
7.5.6. Australia
7.5.6.1. Key country dynamics
7.5.6.2. Competitive scenario
7.5.6.3. Regulatory framework
7.5.6.4. Reimbursement scenario
7.5.6.5. Australia prostatic artery embolization market estimates and forecasts, 2021 - 2033 (USD Million)
7.5.7. Thailand
7.5.7.1. Key country dynamics
7.5.7.2. Competitive scenario
7.5.7.3. Regulatory framework
7.5.7.4. Reimbursement scenario
7.5.7.5. Thailand prostatic artery embolization market estimates and forecasts, 2021 - 2033 (USD Million)
7.6. Latin America
7.6.1. Latin America prostatic artery embolization market estimates and forecasts, 2021 - 2033 (USD Million)
7.6.2. Brazil
7.6.2.1. Key country dynamics
7.6.2.2. Competitive scenario
7.6.2.3. Regulatory framework
7.6.2.4. Reimbursement scenario
7.6.2.5. Brazil prostatic artery embolization market estimates and forecasts, 2021 - 2033 (USD Million)
7.6.3. Argentina
7.6.3.1. Key country dynamics
7.6.3.2. Competitive scenario
7.6.3.3. Regulatory framework
7.6.3.4. Reimbursement scenario
7.6.3.5. Argentina prostatic artery embolization market estimates and forecasts, 2021 - 2033 (USD Million)
7.7. Middle East and Africa
7.7.1. Middle East and Africa prostatic artery embolization market estimates and forecasts, 2021 - 2033 (USD Million)
7.7.2. South Africa
7.7.2.1. Key country dynamics
7.7.2.2. Competitive scenario
7.7.2.3. Regulatory framework
7.7.2.4. Reimbursement scenario
7.7.2.5. South Africa prostatic artery embolization market estimates and forecasts, 2021 - 2033 (USD Million)
7.7.3. Saudi Arabia
7.7.3.1. Key country dynamics
7.7.3.2. Competitive scenario
7.7.3.3. Regulatory framework
7.7.3.4. Reimbursement scenario
7.7.3.5. Saudi Arabia prostatic artery embolization market estimates and forecasts, 2021 - 2033 (USD Million)
7.7.4. UAE
7.7.4.1. Key country dynamics
7.7.4.2. Competitive scenario
7.7.4.3. Regulatory framework
7.7.4.4. Reimbursement scenario
7.7.4.5. UAE prostatic artery embolization market estimates and forecasts, 2021 - 2033 (USD Million)
7.7.5. Kuwait
7.7.5.1. Key country dynamics
7.7.5.2. Competitive scenario
7.7.5.3. Regulatory framework
7.7.5.4. Reimbursement scenario
7.7.5.5. Kuwait prostatic artery embolization market estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis by Key Market Participants
8.2. Company Categorization
8.3. Company Market Share Analysis, 2025
8.4. Company Heat Map Analysis
8.5. Strategy Mapping
8.5.1. Expansion
8.5.2. Mergers & Acquisition
8.5.3. Partnerships & Collaborations
8.5.4. New Technology Launches
8.5.5. Research and Development
8.5.6. Company Profiles
8.5.7. Merit Medical Systems, Inc.
8.5.7.1. Company overview
8.5.7.2. Financial performance
8.5.7.3. Product Benchmarking
8.5.7.4. Strategic initiatives
8.5.8. Terumo Medical Corporation
8.5.8.1. Company overview
8.5.8.2. Financial performance
8.5.8.3. Product Benchmarking
8.5.8.4. Strategic initiatives
8.5.9. Boston Scientific Corporation
8.5.9.1. Company overview
8.5.9.2. Financial performance
8.5.9.3. Product Benchmarking
8.5.9.4. Strategic initiatives
8.5.10. Cook Medical LLC
8.5.10.1. Company overview
8.5.10.2. Financial performance
8.5.10.3. Product Benchmarking
8.5.10.4. Strategic initiatives
8.5.11. Embolx, Inc.
8.5.11.1. Company overview
8.5.11.2. Financial performance
8.5.11.3. Product Benchmarking
8.5.11.4. Strategic initiatives
8.5.12. Varian Medical Systems, Inc. (Siemens Healthineers Company)
8.5.12.1. Company overview
8.5.12.2. Financial performance
8.5.12.3. Product Benchmarking
8.5.12.4. Strategic initiatives
8.5.13. Accurate Medical Therapeutics (Guerbet)
8.5.13.1. Company overview
8.5.13.2. Financial performance
8.5.13.3. Product Benchmarking
8.5.13.4. Strategic initiatives
8.5.14. Asahi Intecc
8.5.14.1. Company overview
8.5.14.2. Financial performance
8.5.14.3. Product Benchmarking
8.5.14.4. Strategic initiatives
8.5.15. Penumbra, Inc.
8.5.15.1. Company overview
8.5.15.2. Financial performance
8.5.15.3. Product Benchmarking
8.5.15.4. Strategic initiatives
8.5.16. Cordis Corporation
8.5.16.1. Company overview
8.5.16.2. Financial performance
8.5.16.3. Product Benchmarking
8.5.16.4. Strategic initiatives
8.5.17. Medtronic plc
8.5.17.1. Company overview
8.5.17.2. Financial performance
8.5.17.3. Product Benchmarking
8.5.17.4. Strategic initiatives
List of Tables
Table 1 List of Abbreviations
Table 2 North America Prostatic Artery Embolization Market, Product, 2021 - 2033 (USD Million)
Table 3 North America Prostatic Artery Embolization Market, Application, 2021 - 2033 (USD Million)
Table 4 North America Prostatic Artery Embolization Market, End Use, 2021 - 2033 (USD Million)
Table 5 U.S. Prostatic Artery Embolization Market, Product, 2021 - 2033 (USD Million)
Table 6 U.S. Prostatic Artery Embolization Market, Application, 2021 - 2033 (USD Million)
Table 7 U.S. Prostatic Artery Embolization Market, End Use, 2021 - 2033 (USD Million)
Table 8 Canada Prostatic Artery Embolization Market, Product, 2021 - 2033 (USD Million)
Table 9 Canada Prostatic Artery Embolization Market, Application, 2021 - 2033 (USD Million)
Table 10 Canada Prostatic Artery Embolization Market, End Use, 2021 - 2033 (USD Million)
Table 11 Mexico Prostatic Artery Embolization Market, Product, 2021 - 2033 (USD Million)
Table 12 Mexico Prostatic Artery Embolization Market, Application, 2021 - 2033 (USD Million)
Table 13 Mexico Prostatic Artery Embolization Market, End Use, 2021 - 2033 (USD Million)
Table 14 Europe Prostatic Artery Embolization Market, Product, 2021 - 2033 (USD Million)
Table 15 Europe Prostatic Artery Embolization Market, Application, 2021 - 2033 (USD Million)
Table 16 Europe Prostatic Artery Embolization Market, End Use, 2021 - 2033 (USD Million)
Table 17 Germany Prostatic Artery Embolization Market, Product, 2021 - 2033 (USD Million)
Table 18 Germany Prostatic Artery Embolization Market, Application, 2021 - 2033 (USD Million)
Table 19 Germany Prostatic Artery Embolization Market, End Use, 2021 - 2033 (USD Million)
Table 20 UK Prostatic Artery Embolization Market, Product, 2021 - 2033 (USD Million)
Table 21 UK Prostatic Artery Embolization Market, Application, 2021 - 2033 (USD Million)
Table 22 UK Prostatic Artery Embolization Market, End Use, 2021 - 2033 (USD Million)
Table 23 France Prostatic Artery Embolization Market, Product, 2021 - 2033 (USD Million)
Table 24 France Prostatic Artery Embolization Market, Application, 2021 - 2033 (USD Million)
Table 25 France Prostatic Artery Embolization Market, End Use, 2021 - 2033 (USD Million)
Table 26 Italy Prostatic Artery Embolization Market, Product, 2021 - 2033 (USD Million)
Table 27 Italy Prostatic Artery Embolization Market, Application, 2021 - 2033 (USD Million)
Table 28 Italy Prostatic Artery Embolization Market, End Use, 2021 - 2033 (USD Million)
Table 29 Spain Prostatic Artery Embolization Market, Product, 2021 - 2033 (USD Million)
Table 30 Spain Prostatic Artery Embolization Market, Application, 2021 - 2033 (USD Million)
Table 31 Spain Prostatic Artery Embolization Market, End Use, 2021 - 2033 (USD Million)
Table 32 Denmark Prostatic Artery Embolization Market, Product, 2021 - 2033 (USD Million)
Table 33 Denmark Prostatic Artery Embolization Market, Application, 2021 - 2033 (USD Million)
Table 34 Denmark Prostatic Artery Embolization Market, End Use, 2021 - 2033 (USD Million)
Table 35 Sweden Prostatic Artery Embolization Market, Product, 2021 - 2033 (USD Million)
Table 36 Sweden Prostatic Artery Embolization Market, Application, 2021 - 2033 (USD Million)
Table 37 Sweden Prostatic Artery Embolization Market, End Use, 2021 - 2033 (USD Million)
Table 38 Norway Prostatic Artery Embolization Market, Product, 2021 - 2033 (USD Million)
Table 39 Norway Prostatic Artery Embolization Market, Application, 2021 - 2033 (USD Million)
Table 40 Norway Prostatic Artery Embolization Market, End Use, 2021 - 2033 (USD Million)
Table 41 Asia Pacific Prostatic Artery Embolization Market, Product, 2021 - 2033 (USD Million)
Table 42 Asia Pacific Prostatic Artery Embolization Market, Application, 2021 - 2033 (USD Million)
Table 43 Asia Pacific Prostatic Artery Embolization Market, End Use, 2021 - 2033 (USD Million)
Table 44 China Prostatic Artery Embolization Market, Product, 2021 - 2033 (USD Million)
Table 45 China Prostatic Artery Embolization Market, Application, 2021 - 2033 (USD Million)
Table 46 China Prostatic Artery Embolization Market, End Use, 2021 - 2033 (USD Million)
Table 47 India Prostatic Artery Embolization Market, Product, 2021 - 2033 (USD Million)
Table 48 India Prostatic Artery Embolization Market, Application, 2021 - 2033 (USD Million)
Table 49 India Prostatic Artery Embolization Market, End Use, 2021 - 2033 (USD Million)
Table 50 Japan Prostatic Artery Embolization Market, Product, 2021 - 2033 (USD Million)
Table 51 Japan Prostatic Artery Embolization Market, Application, 2021 - 2033 (USD Million)
Table 52 Japan Prostatic Artery Embolization Market, End Use, 2021 - 2033 (USD Million)
Table 53 Australia Prostatic Artery Embolization Market, Product, 2021 - 2033 (USD Million)
Table 54 Australia Prostatic Artery Embolization Market, Application, 2021 - 2033 (USD Million)
Table 55 Australia Prostatic Artery Embolization Market, End Use, 2021 - 2033 (USD Million)
Table 56 South Korea Prostatic Artery Embolization Market, Product, 2021 - 2033 (USD Million)
Table 57 South Korea Prostatic Artery Embolization Market, Application, 2021 - 2033 (USD Million)
Table 58 South Korea Prostatic Artery Embolization Market, End Use, 2021 - 2033 (USD Million)
Table 59 Thailand Prostatic Artery Embolization Market, Product, 2021 - 2033 (USD Million)
Table 60 Thailand Prostatic Artery Embolization Market, Application, 2021 - 2033 (USD Million)
Table 61 Thailand Prostatic Artery Embolization Market, End Use, 2021 - 2033 (USD Million)
Table 62 Latin America Prostatic Artery Embolization Market, Product, 2021 - 2033 (USD Million)
Table 63 Latin America Prostatic Artery Embolization Market, Application, 2021 - 2033 (USD Million)
Table 64 Latin America Prostatic Artery Embolization Market, End Use, 2021 - 2033 (USD Million)
Table 65 Brazil Prostatic Artery Embolization Market, Product, 2021 - 2033 (USD Million)
Table 66 Brazil Prostatic Artery Embolization Market, Application, 2021 - 2033 (USD Million)
Table 67 Brazil Prostatic Artery Embolization Market, End Use, 2021 - 2033 (USD Million)
Table 68 Argentina Prostatic Artery Embolization Market, Product, 2021 - 2033 (USD Million)
Table 69 Argentina Prostatic Artery Embolization Market, Application, 2021 - 2033 (USD Million)
Table 70 Argentina Prostatic Artery Embolization Market, End Use, 2021 - 2033 (USD Million)
Table 71 MEA Prostatic Artery Embolization Market, Product, 2021 - 2033 (USD Million)
Table 72 MEA Prostatic Artery Embolization Market, Application, 2021 - 2033 (USD Million)
Table 73 MEA Prostatic Artery Embolization Market, End Use, 2021 - 2033 (USD Million)
Table 74 South Africa Prostatic Artery Embolization Market, Product, 2021 - 2033 (USD Million)
Table 75 South Africa Prostatic Artery Embolization Market, Application, 2021 - 2033 (USD Million)
Table 76 South Africa Prostatic Artery Embolization Market, End Use, 2021 - 2033 (USD Million)
Table 77 Saudi Arabia Prostatic Artery Embolization Market, Product, 2021 - 2033 (USD Million)
Table 78 Saudi Arabia Prostatic Artery Embolization Market, Application, 2021 - 2033 (USD Million)
Table 79 Saudi Arabia Prostatic Artery Embolization Market, End Use, 2021 - 2033 (USD Million)
Table 80 UAE Prostatic Artery Embolization Market, Product, 2021 - 2033 (USD Million)
Table 81 UAE Prostatic Artery Embolization Market, Application, 2021 - 2033 (USD Million)
Table 82 UAE Prostatic Artery Embolization Market, End Use, 2021 - 2033 (USD Million)
Table 83 Kuwait Prostatic Artery Embolization Market, Product, 2021 - 2033 (USD Million)
Table 84 Kuwait Prostatic Artery Embolization Market, Application, 2021 - 2033 (USD Million)
Table 85 Kuwait Prostatic Artery Embolization Market, End Use, 2021 - 2033 (USD Million)
List of Figures
Figure 1 List Of Abbreviations
Figure 2 Prostatic Artery Embolization Market Segmentation
Figure 3 Market Research Process
Figure 4 Information Procurement
Figure 5 Data Analysis Models
Figure 6 Market Formulation And Validation
Figure 7 Data Validating & Publishing
Figure 8 Market Snapshot
Figure 9 Segment Snapshot
Figure 10 Competitive Landscape Snapshot
Figure 11 Prostatic Artery Embolization Market Size And Growth Prospects (USD Million)
Figure 12 Prostatic Artery Embolization Market: Industry Value Chain Analysis
Figure 13 Prostatic Artery Embolization Market: Market Dynamics
Figure 14 Prostatic Artery Embolization Market: PORTER's Analysis
Figure 15 Prostatic Artery Embolization Market: PESTEL Analysis
Figure 16 Prostatic Artery Embolization Market Share by Product, 2025 & 2033 (USD Million)
Figure 17 Prostatic Artery Embolization Market, Product: Market Share, 2025 & 2033
Figure 18 Embolic Agents Market Estimates & Forecasts, 2021 - 2033 (Revenue, USD Million)
Figure 19 Spherical Microspheres Market Estimates & Forecasts, 2021 - 2033 (Revenue, USD Million)
Figure 20 Tris-Acryl Gelatin Microspheres Market Estimates & Forecasts, 2021 - 2033 (Revenue, USD Million)
Figure 21 PVA-Based Microspheres Market Estimates & Forecasts, 2021 - 2033 (Revenue, USD Million)
Figure 22 Hydrogel Microspheres Market Estimates & Forecasts, 2021 - 2033 (Revenue, USD Million)
Figure 23 Non-Spherical Polyvinyl Alcohol (PVA) Particles Market Estimates & Forecasts, 2021 - 2033 (Revenue, USD Million)
Figure 24 Other Embolic Agents Market Estimates & Forecasts, 2021 - 2033 (Revenue, USD Million)
Figure 25 Delivery And Access Devices Market Estimates & Forecasts, 2021 - 2033 (Revenue, USD Million)
Figure 26 Microcatheters Market Estimates & Forecasts, 2021 - 2033 (Revenue, USD Million)
Figure 27 Standard Microcatheters Market Estimates & Forecasts, 2021 - 2033 (Revenue, USD Million)
Figure 28 Reflux-Control Microcatheters Market Estimates & Forecasts, 2021 - 2033 (Revenue, USD Million)
Figure 29 Balloon-Occlusion Microcatheters Market Estimates & Forecasts, 2021 - 2033 (Revenue, USD Million)
Figure 30 Steerable Microcatheters Market Estimates & Forecasts, 2021 - 2033 (Revenue, USD Million)
Figure 31 Guidewires And Micro Guidewires Market Estimates & Forecasts, 2021 - 2033 (Revenue, USD Million)
Figure 32 Diagnostic/ Guiding Catheters Market Estimates & Forecasts, 2021 - 2033 (Revenue, USD Million)
Figure 33 Other Procedural Accessories Market Estimates & Forecasts, 2021 - 2033 (Revenue, USD Million)
Figure 34 Prostatic Artery Embolization Market Share by Application, 2025 & 2033 (USD Million)
Figure 35 Prostatic Artery Embolization Market, Application: Market Share, 2025 & 2033
Figure 36 Benign Prostatic Hyperplasia (BPH) Market Estimates & Forecasts, 2021 - 2033 (Revenue, USD Million)
Figure 37 Urinary Retention Market Estimates & Forecasts, 2021 - 2033 (Revenue, USD Million)
Figure 38 Prostatic Bleeding Market Estimates & Forecasts, 2021 - 2033 (Revenue, USD Million)
Figure 39 Prostate Cancer Symptom Management Market Estimates & Forecasts, 2021 - 2033 (Revenue, USD Million)
Figure 40 Other Prostatic Conditions Market Estimates & Forecasts, 2021 - 2033 (Revenue, USD Million)
Figure 41 Prostatic Artery Embolization Market Share by End Use, 2025 & 2033 (USD Million)
Figure 42 Prostatic Artery Embolization Market, End Use: Market Share, 2025 & 2033
Figure 43 Hospitals & Academic Medical Centers Market Estimates & Forecasts, 2021 - 2033 (Revenue, USD Million)
Figure 44 Ambulatory Surgical Centers Market Estimates & Forecasts, 2021 - 2033 (Revenue, USD Million)
Figure 45 Office-Based Labs (Obls) & Outpatient IR Clinics Market Estimates & Forecasts, 2021 - 2033 (Revenue, USD Million)
Figure 46 Regional Marketplace: Key Takeaways
Figure 47 North America Prostatic Artery Embolization Market Estimates And Forecasts, 2021 - 2033 (USD Million)
Figure 48 U.S. Prostatic Artery Embolization Market Estimates And Forecasts, 2021 - 2033 (USD Million)
Figure 49 Canada Prostatic Artery Embolization Market Estimates And Forecasts, 2021 - 2033 (USD Million)
Figure 50 Mexico Prostatic Artery Embolization Market Estimates And Forecasts, 2021 - 2033 (USD Million)
Figure 51 Europe Prostatic Artery Embolization Market Estimates And Forecasts, 2021 - 2033 (USD Million)
Figure 52 UK Prostatic Artery Embolization Market Estimates And Forecasts, (2021 - 2033) (USD Million)
Figure 53 Germany Prostatic Artery Embolization Market Estimates And Forecasts, (2021 - 2033) (USD Million)
Figure 54 France Prostatic Artery Embolization Market Estimates And Forecasts, (2021 - 2033) (USD Million)
Figure 55 Italy Prostatic Artery Embolization Market Estimates And Forecasts, (2021 - 2033) (USD Million)
Figure 56 Spain Prostatic Artery Embolization Market Estimates And Forecasts, (2021 - 2033) (USD Million)
Figure 57 Sweden Prostatic Artery Embolization Market Estimates And Forecasts, (2021 - 2033) (USD Million)
Figure 58 Denmark Prostatic Artery Embolization Market Estimates And Forecasts, (2021 - 2033) (USD Million)
Figure 59 Norway Prostatic Artery Embolization Market Estimates And Forecasts, (2021 - 2033) (USD Million)
Figure 60 Asia Pacific Prostatic Artery Embolization Market Estimates And Forecast, 2021 - 2033 (USD Million)
Figure 61 China Prostatic Artery Embolization Market Estimates And Forecasts, 2021 - 2033 (USD Million)
Figure 62 Japan Prostatic Artery Embolization Market Estimates And Forecasts, 2021 - 2033 (USD Million)
Figure 63 India Prostatic Artery Embolization Market Estimates And Forecasts, 2021 - 2033 (USD Million)
Figure 64 South Korea Prostatic Artery Embolization Market Estimates And Forecasts, 2021 - 2033 (USD Million)
Figure 65 Australia Prostatic Artery Embolization Market Estimates And Forecasts, 2021 - 2033 (USD Million)
Figure 66 Thailand Prostatic Artery Embolization Market Estimates And Forecasts, 2021 - 2033 (USD Million)
Figure 67 Latin America Prostatic Artery Embolization Market Estimates And Forecasts, 2021 - 2033 (USD Million)
Figure 68 Brazil Prostatic Artery Embolization Market Estimates And Forecasts, 2021 - 2033 (USD Million)
Figure 69 Argentina Prostatic Artery Embolization Market Estimates And Forecasts, 2021 - 2033 (USD Million)
Figure 70 MEA Prostatic Artery Embolization Market Estimates And Forecasts, 2021 - 2033 (USD Million)
Figure 71 South Africa Prostatic Artery Embolization Market Estimates And Forecasts, 2021 - 2033 (USD Million)
Figure 72 Saudi Arabia Prostatic Artery Embolization Market Estimates And Forecasts, 2021 - 2033 (USD Million)
Figure 73 UAE Prostatic Artery Embolization Market Estimates And Forecasts, 2021 - 2033 (USD Million)
Figure 74 Kuwait Prostatic Artery Embolization Market Estimates And Forecasts, 2021 - 2033 (USD Million)
Figure 75 Key Company Categorization
Figure 76 Company Market Positioning
Figure 77 Key Company Market Share Analysis, 2025
Figure 78 Strategic Framework

Companies Mentioned

  • Merit Medical Systems, Inc.
  • Terumo Medical Corporation
  • Boston Scientific Corporation
  • Cook Medical LLC
  • Embolx, Inc.
  • Varian Medical Systems, Inc. (Siemens Healthineers Company)
  • Accurate Medical Therapeutics (Guerbet)
  • Asahi Intecc
  • Penumbra, Inc.
  • Cordis Corporation
  • Medtronic plc